← Back to All Filings

CervoMed CFO Buys $26K in CRVO Stock, Increasing Holdings

Low SignificanceNovember 13, 2025 at 9:02:22 AM EST

CervoMed Inc.

$CRVO4CIK: 0001053691

Subscribe to track CRVO

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

CervoMed CFO Buys $26K in CRVO Stock

Company: CervoMed Inc. (CRVO) Form: 4 | Filed: 2025-11-13 Significance: Low

Insider: ELDER WILLIAM ROBERT Title: CFO, GC & Secretary | Relationship: Officer

Transaction: • Type: Buy • Shares: 3,500 • Price: $7.44 • Value: $26,040 • Owned After: 9,000

Key Insight: A low-value open-market purchase by the CFO. While a positive signal of confidence, the transaction size is not material, representing less than 0.05% of the company's market cap.

Market Context: The purchase occurs in a small-cap pharmaceutical company, where insider transactions are closely watched, but this trade's size limits its impact.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: CervoMed Inc. (CRVO)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The CFO of CervoMed Inc. executed a small open-market purchase of common stock valued at approximately $26,000.
  • Market Impact: The transaction is too small relative to the company's market capitalization to have a significant market impact.

Company Information

FieldValue
CompanyCervoMed Inc.
Ticker SymbolCRVO
CIK0001053691
IndustryPHARMACEUTICAL PREPARATIONS

Insider Information

FieldValue
NameELDER WILLIAM ROBERT
CIK0001828068
Title/PositionCFO, GC & Secretary
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-12
Transaction CodeP (Open market purchase)
Security TypeCommon Stock
Shares Involved3,500
Price Per Share$7.44
Total Value$26,040
Shares Owned After9,000
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$26,040
% of Market Cap0.043%
Shares Transacted3,500
% of Shares Outstanding0.038%
Post-Transaction Ownership9,000 shares (0.097% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a $60 million market capitalization, this $26,040 transaction is financially minor.
  • Ownership Concentration: The CFO's post-transaction holding of 9,000 shares constitutes a very small ownership stake (less than 0.1%) relative to the total shares outstanding.
  • Transaction Significance: The purchase is categorized as having low significance because its value is less than 0.1% of the company's market cap and the shares involved are less than 0.1% of the shares outstanding.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction value is insignificant compared to the company's market capitalization and typical daily trading volume.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The trade size is too small to affect trading volume.
  • Sentiment Indicator: Neutral. While an insider buy is a positive signal, the small scale of this transaction is unlikely to influence broader market sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's footnote confirms the shares were acquired via an open-market purchase.
Topics:#SECFiling#InsiderTrading#CRVO#CervoMed#Form4#InsiderBuy#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.